Managing tuberculosis in patients with diabetes mellitus: why we care and what we know

被引:0
|
作者
Jeon, Christie Y. [1 ]
Murray, Megan B. [2 ,3 ]
Baker, Meghan A. [4 ,5 ,6 ]
机构
[1] Columbia Univ, Sch Nursing, New York, NY 10032 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA
[4] Harvard Univ, Dept Populat Med, Sch Med, Boston, MA USA
[5] Harvard Pilgrim Hlth Care Inst, Boston, MA USA
[6] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA
关键词
antibiotic treatment; diabetes mellitus; glucose control; tuberculosis; PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; PHARMACOKINETICS; PREVALENCE; RISK; MICE; SUSCEPTIBILITY; CONVERGENCE; EPIDEMICS; INFECTION;
D O I
10.1586/ERI.12.75
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
As the global prevalence of diabetes mellitus (DM) increases, especially in low-to-middle income countries where tuberculosis (TB) remains endemic, we will encounter a growing number of TB patients with DM. This is a major concern for TB control programs, clinicians and patients alike because DM patients are at an increased risk of TB and are more likely to face poor TB treatment outcomes, including treatment failure, relapse and even death. Priority should be placed on early detection of both diseases through active screening, monitoring of adherence to medications for both diseases, and integration of TB and DM management strategies that would facilitate the provision of more comprehensive services that TB patients with DM require.
引用
收藏
页码:863 / 868
页数:6
相关论文
共 50 条
  • [1] Skin and diabetes mellitus: what do we know?
    Quondamatteo, Fabio
    CELL AND TISSUE RESEARCH, 2014, 355 (01) : 1 - 21
  • [2] Skin and diabetes mellitus: what do we know?
    Fabio Quondamatteo
    Cell and Tissue Research, 2014, 355 : 1 - 21
  • [3] What We Know About Tuberculosis Transmission: An Overview
    Churchyard, Gavin
    Kim, Peter
    Shah, N. Sarita
    Rustomjee, Roxana
    Gandhi, Neel
    Mathema, Barun
    Dowdy, David
    Kasmar, Anne
    Cardenas, Vicky
    JOURNAL OF INFECTIOUS DISEASES, 2017, 216 : S629 - S635
  • [4] Clinical Research in Diabetes and Urinary Incontinence: What We Know and Need to Know
    Phelan, Suzanne
    Grodstein, Francine
    Brown, Jeanette S.
    JOURNAL OF UROLOGY, 2009, 182 (06): : S14 - S17
  • [5] Links between diabetes mellitus and tuberculosis: should we integrate screening and care?
    Harries, Anthony D.
    Billo, Nils
    Kapur, Anil
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2009, 103 (01) : 1 - 2
  • [6] Venous thromboembolism in palliative care patients: what do we know?
    Noble, Simon
    THROMBOSIS RESEARCH, 2020, 191 : S128 - S132
  • [7] Illicit drugs in Central Asia: What we know, what we don't know, and what we need to know
    Latypov, Alisher
    Grund, Jean-Paul
    El-Bassel, Nabila
    Platt, Lucy
    Stoever, Heino
    Strathdee, Steffanie
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2014, 25 (06) : 1155 - 1162
  • [8] Screening of patients with Diabetes Mellitus for Tuberculosis in Community Health Settings in China
    Lin, Yan
    Innes, Anh
    Xu, Lin
    Li, Ling
    Chen, Jinou
    Hou, Jinglong
    Mi, Fengling
    Kang, Wanli
    Harries, Anthony D.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 (08) : 1073 - 1080
  • [9] Chikungunya and diabetes, what do we know?
    de Almeida Barreto, Francisca Kalline
    Montenegro, Renan Magalhaes, Jr.
    Fernandes, Virginia Oliveira
    Oliveira, Rhaquel
    de Araujo Batista, Livia Aline
    Hussain, Akhtar
    de Goes Cavalcanti, Luciano Pamplona
    DIABETOLOGY & METABOLIC SYNDROME, 2018, 10
  • [10] Chikungunya and diabetes, what do we know?
    Francisca Kalline de Almeida Barreto
    Renan Magalhães Montenegro
    Virginia Oliveira Fernandes
    Rhaquel Oliveira
    Lívia Aline de Araújo Batista
    Akhtar Hussain
    Luciano Pamplona de Góes Cavalcanti
    Diabetology & Metabolic Syndrome, 10